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The imprinting of mammalian genes depends on the maintenance of DNA methylation patterns during pre- and
postimplantation development. Dnmt1o is a variant form of the somatically expressed Dnmt1 cytosine methyltransferase
that is synthesized and stored in the oocyte cytoplasm and trafficks to the eight-cell nucleus during preimplantation
development, where it maintains DNA methylation patterns on alleles of imprinted genes. Transcripts encoding Dnmt1 are
present in preimplantation embryos, suggesting that Dnmt1 protein is also expressed in the preimplantation embryo, and
may account for maintenance methylation at preimplantation stages other than the eight-cell embryo. However, using an
antibody that detects Dnmt1, but not Dnmt1o, no Dnmt1 protein was detected on immunoblots or by immunocytochemi-
cal staining in wildtype preimplantation embryos. Moreover, Dnmt1 protein produced in the oocyte from a modified Dnmt1
allele, Dnmt11s/1o, trafficked to nuclei of eight-cell embryos, but not to nuclei of other stages. The highly restricted nuclear
localization patterns of oocyte-derived Dnmt1o and Dnmt1 during preimplantation development add further support to the
notion that DNA methyltransferases other than Dnmt1 are required for maintaining imprints during preimplantation
development. © 2002 Elsevier Science (USA)
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The predominant form of DNA (cytosine-5)-methyl-
transferase in mammals is Dnmt1, a protein of relative mo-
lecular weight 190,000 (Mr 190,000) composed of a large
amino-terminal regulatory domain and a smaller carboxy-
terminal catalytic domain that is closely related to bacterial
C5-specific restriction methyltransferases (Bestor, 2000). Se-
quences within the N-terminal domain are required for the
1 These authors contributed equally to this work.
2 To whom correspondence should be addressed. Fax: (514) 412-4331. E-mail: jacquetta.trasler@mcgill.ca.
304localization of Dnmt1 to the nucleus and to replication foci
during S-phase (Leonhardt et al., 1992). Although Dnmt1
catalyzes both de novo and maintenance methylation in vitro,
it has a 5- to 30-fold preference for hemimethylated DNA
substrates over unmethylated substrates (Yoder et al., 1997),
suggesting that its main role, or only role, in mammalian
organisms is to maintain DNA methylation patterns. Ho-
mozygous mutant ES cells and embryos derived from matings
between parents heterozygous for Dnmt1 null alleles have
marked reductions in Dnmt1 and in the level of CpG meth-
ylation (Lei et al., 1996). The residual methylation appears to
be confined to repetitive DNA sequences, whose methylation
may be due to other DNA (cytosine-5)-methyltransferases.
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Genes encoding Dnmt1-like proteins, such as Dnmt3a and
Dnmt3b, have recently been cloned and their methyltrans-
ferase activities measured. In vitro, Dnmt3a and Dnmt3b
primarily possess de novo methyltransferase activities (Okano
et al., 1998, 1999; Xu et al., 1999). Moreover, the majority of
genomic methylation is retained when Dnmt3a and Dnmt3b
are removed from the developing embryo, consistent with a
lack of any significant contribution to maintaining methyl-
ation patterns (Okano et al., 1999). These observations on
Dnmt1 and Dnmt1-related proteins in the mouse have raised
the possibility that Dnmt1 provides all of the maintenance
methyltransferase activity in the mammalian organism.
The Dnmt1 protein is abundantly expressed in cells of
the developing embryo, and it is readily detected in nuclei
of all cells of the early postimplantation embryo (Trasler et
al., 1996; Yoder et al., 1997). However, Dnmt1 protein has
not been detected in oocytes and in cells of preimplantation
embryos (Cardoso and Leonhardt, 1999; Carlson et al.,
1992; Mertineit et al., 1998). In these stages, there is an
abundance of a variant Dnmt1 protein called Dnmt1o, with
a relative molecular weight of 175,000 (Mr 175,000).
Dnmt1o protein is synthesized from an oocyte-specific
transcript, which is translated into a truncated version of
Dnmt1 that is missing its N-terminal 118 amino acids
(Mertineit et al., 1998). Dnmt1o protein is in the cytoplasm
of the mature metaphase II (MII) oocyte, and in the cyto-
plasm of all preimplantation cleavage stages, but is only
found in the nucleus of blastomeres at the eight-cell stage
(Cardoso and Leonhardt, 1999; Carlson et al., 1992; Howell
et al., 2001; Mertineit et al., 1998). Studies in mice homozy-
gous for a targeted disruption of the Dnmt1 oocyte-specific
promoter indicate that preimplantation Dnmt1o protein is
derived from the oocyte’s cytoplasmic Dnmt1o (Howell et
al., 2001). Heterozygous mutant embryos derived from
homozygous mutant oocytes lack Dnmt1o protein during
their preimplantation development and have a 50% reduc-
tion in methylated alleles of imprinted genes, most likely
because the loss of nuclear Dnmt1o protein at the eight-cell
stage leads to a loss of maintenance methylation in eight-
cell blastomeres. The proteins that supply the maintenance
methyltransferase activity for the other S phases of preim-
plantation development are unknown.
Genetic experiments to examine the role of Dnmt1 in
maintaining methylation patterns during preimplantation
development have not been described. The possibility of an
oocyte Dnmt1 contribution cannot be easily tested because
of the lethal nature of the constitutive Dnmt1 null muta-
tion (Lei et al., 1996) and the difficulty in devising a
conditional Dnmt1 mutation that selectively removes
Dnmt1 protein from all stages of oogenesis. In addition to
oocyte sources of Dnmt1, embryonically expressed Dnmt1
might also be involved in maintaining imprints during
preimplantation development. It would be feasible, al-
though quite difficult, to test this possibility. Dnmt1 is
known to maintain virtually all DNA methylation in the
postimplantation embryo, and is an essential protein for
postimplantation embryonic development (Lei et al., 1996).
Therefore, a genetic test of whether or not Dnmt1 protein
that is made in the preimplantation embryo contributes to
the maintenance of methylation patterns on imprinted
genes would require the measurement of methylation pat-
terns in preimplantation embryos that are homozygous for
a null Dnmt1 allele. The presence of unmethylated copies
of parental alleles that normally maintain their gametic
methylation would implicate Dnmt1 in the maintenance of
imprinted methylation patterns during preimplantation de-
velopment.
In lieu of genetic experiments to decipher the role of
Dnmt1 in maintaining methylation patterns during preim-
plantation development, we measured Dnmt1 expression
and intracellular localization in oocytes and cleavage-stage
preimplantation embryos. In addition to measuring Dnmt1
and Dnmt1o mRNAs, we used three different antibodies to
determine the levels and intracellular locations of Dnmt1
and Dnmt1o proteins. One antibody detects epitopes found
only in Dnmt1 and the other two detect epitopes found in
both Dnmt1 and Dnmt1o. The antibodies were used to
detect Dnmt1 and Dnmt1o on immunoblots or by immu-
nostaining individual oocytes or preimplantation-stage em-
bryos. Finally, we used the Dnmt1-specific antibody to
follow the fate of a large maternal contribution of Dnmt1
protein produced in a mouse line containing a modified
Dnmt1 locus.
MATERIALS AND METHODS
Animals
All wild-type tissues, oocytes, and embryos were obtained from
CD-1 mice (Charles River Canada, St. Constant, QC). The engineered
mouse line with a modified Dnmt1 allele, in which exon 1o was
replaced with exon 1s sequences, is designated Dnmt11s/1o. Standard
gene modification methods were used to produce the targeting vector
for this allele (see Fig. 5), which was then transferred into W9.5 ES
cells (gift of C. Stewart). Excision of the resistance cassette after
electroporation of a Cre recombinase-expressing plasmid was con-
firmed by PCR with primers of sequence 5-AGGAAAACAGT-
GGAGGAAAC-3 and 5-TACTTGCACAGGGCTGTCCT-3. Oo-
cytes and preimplantation embryos were obtained from Dnmt11s/1o
females on a mixed 129/Sv and C57BL/6 background. Noon of the day
on which a vaginal plug was found was designated embryonic day 0.5
(E0.5) and the day of delivery as postnatal day 1 (D1). Embryos from
timed pregnant females were removed from the uterine horns at E7.5
and at E17.5–E18.5. Testes and ovaries could be distinguished in
embryos at E12.5 and later by the presence or absence of seminiferous
cords, respectively (Hogan et al., 1986).
Collection of Oocytes and Embryos
Immature oocytes in prophase I of meiosis were collected at
E17.5–E18.5, D1 (at birth), D5, D10, and D15 (Eppig and Telfer,
1993). Ovaries from three or four mice were dissected in phosphate-
buffered saline (PBS), pH 7.2, teased into smaller pieces, and
transferred to 2 ml of PBS, 2 mg/ml collagenase (Sigma), 0.025%
trypsin (Gibco BRL, Burlington, ON) and 0.02 mg/ml DNase
(Sigma). The tube was capped tightly and shaken at high speed for
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10 min at 37°C, and the contents were subsequently diluted with
one volume of Hepes-buffered minimal essential medium, MEM-H
(Gibco BRL), modified as described (Clarke et al., 1988; Schroeder
and Eppig, 1984). Oocytes were collected individually by a micropi-
pette from the dissociated ovaries.
Fully grown, germinal vesicle (GV)-stage oocytes were obtained
by puncture of ovarian follicles of 21- to 35-day-old females in
MEM-H supplemented with 100 g/ml of dibutyryl cyclic AMP,
dbcAMP (Sigma), as previously described (Clarke et al., 1992). The
dbcAMP prevents meiotically competent oocytes from undergoing
germinal vesicle breakdown (GVBD) in culture (Cho et al., 1974).
GVBD oocytes were derived from GV oocytes that were isolated in
MEM-H free of dbcAMP and incubated in 5-l drops of bicarbonate-
buffered MEM under oil at 37°C in an atmosphere of 5% CO2 in air
for 2–4 h.
Metaphase II (MII) oocytes were collected from 7-week-old
females that were superovulated by injection of 7.5 IU of pregnant
mares’ serum gonadotropin, PMSG (Ayerst Vetlabs), followed
44–48 h later by 5 IU of human chorionic gonadotropin, hCG
(Ayerst Vetlabs). These oocytes were recovered from the oviducts
20 h post-hCG, and the cumulus cells were dispersed with 1 mg/ml
hyaluronidase (Roche Diagnostics, Laval, QC), as described (Hogan
et al., 1986).
Preimplantation embryos were obtained as previously described
(Clarke et al., 1992). Superovulated females were caged individu-
ally with stud males overnight, and examined for the presence of a
vaginal plug the next morning. One-cell embryos were recovered
from the oviducts at E0.5 in Hepes-buffered KSOM medium
(Erbach et al., 1994), and the cumulus mass was dispersed as
described above. Two-cell embryos were obtained by flushing the
oviducts of females killed 1.5 days after hCG administration.
Four-cell embryos, eight-cell embryos, morula, and blastocysts
were obtained by culturing two-cell embryos in 5-l drops of
bicarbonate-buffered KSOM or CZB media under oil at 37°C in an
atmosphere of 5% CO2 in air. Postimplantation embryos were
dissected out of the uterine horns at E7.5.
For all isolation procedures, healthy-looking oocytes and pre-
implantation embryos were collected in a 35-mm Petri dish by
using a mouth-controlled micropipette and washed free of any
adhering somatic cells by transfer through two dishes of culture
medium. Oocytes and embryos were either processed immediately
for immunofluorescence or pooled and stored at 80°C in DEPC-
PBS for RNA extraction; stored at 80°C in lysis buffer for
immunoblotting; or stored at 80°C in culture medium for DNA
isolation.
RNA Isolation and RT-PCR
Total RNA was extracted from homogenized tissues by using the
Trizol reagent (Gibco BRL) according to the manufacturer’s instruc-
tions. For isolated oocytes and preimplantation embryos (80 per tube),
10 g of glycogen (Roche Diagnostics) was added to the Trizol and
cellular RNA was recovered as described previously (Clarke et al.,
1997). RNA pellets obtained from these isolated cells were dissolved
in 20 l of DEPC-treated water. The SuperScript One-Step RT-PCR
System (Gibco BRL) was used to analyze transcripts produced by exon
1o and exon 1s of Dnmt1 (Mertineit et al., 1998). Reactions were
performed as directed by the manufacturer. For tissues, 0.5 g of total
FIG. 1. Sex-specific exons and oocyte-specific species of Dnmt1. (A) Organization of sex-specific exons in the 5 end of the Dnmt1 gene.
The oocyte-specific Dnmt1 transcript initiates at exon 1o and is spliced to exon 2; Dnmt1o translation is initiated at the ATG in exon 4
(Mertineit et al., 1998). The resulting protein is 118 amino acids shorter than the somatic form, whose ATG codon is located in exon 1s
(also spliced to exon 2). (B) Comparison of Dnmt1 and Dnmt1o. The difference between the two forms of Dnmt1 proteins is not known to
extend beyond the N-terminal truncation of Dnmt1o. The somatic and oocyte ATG codons are shown, as are a sequence that mediates
interaction of Dnmt1 with replication foci during S phase of somatic cells (Rep. foci), a zinc-binding cysteine-rich domain (Cys-rich), and
a domain that is related to a domain in Polybromo-1 from chicken. (Taken from Bestor, 2000). The epitopes specific to the three antibodies
UPT82, UTC21, and PATH52 are shown in the figure.
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RNA was used in a 25-l RT-PCR. For isolated cells, 10 l of the
dissolved RNA pellet was added to the 25-l RT-PCR. Oligo 5
(Mertineit et al., 1998), 5-GCAGGAATTCATGCAGTAAG-3, is
specific to exon 3, which is common to both Dnmt1 and Dnmt1o
transcripts. Oligo 6 (5-GGGTCTCGTTCAGAGCTG-3) is specific
to exon 1s, and oligo 7 (5-GGTTGATTGAGGGTCATT-3) is spe-
cific to exon 1o (Mertineit et al., 1998). Reverse transcription was
allowed to proceed for 10 min at 50°C then shifted to 55°C for 30 min.
PCR involved 35 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for
60 s. A final extension at 72°C was performed for 7 min. A portion of
the reaction (8 or 10 l) was analyzed by electrophoresis through 12%
polyacrylamide gels.
Immunoblotting
Oocytes and preimplantation embryos were collected manually
from washings of oviducts or uteri and pooled and lysed in 5% SDS,
2.5% glycerol, 2.5% -mercaptoethanol, 0.01% bromophenol blue,
0.025 M Tris–HCl, pH 6.8 (1 sample buffer). Lysates of whole
gonads, accessory reproductive tissues, and postimplantation em-
bryos were prepared by homogenization in 0.15 M NaCl, 0.05 M
Tris–HCl (pH 7.5), 2 g/ml leupeptin, 2 g/ml aprotinin, and 5 mM
phenylmethylsulfonylfluoride, centrifuged, and the supernatant
was added to an equal volume of 2 sample buffer. The amount of
protein in the tissue lysates was quantified by using the amido
black protein spot assay (Dieckmann-Schuppert and Schnittler,
1997). All samples were denatured by heating at 95°C for 5 min,
and then separated by electrophoresis on SDS-5% polyacrylamide
gels. Afterwards, they were transferred to Hybond ECL nitrocellu-
lose membranes (Pharmacia Biotech, Baie d’Urfe´, QC). The gels
were stained with Coomassie Blue to examine the efficiency of
protein transfer and membranes were stained with Ponceau S to
confirm the presence of the appropriate amount of protein in all
lanes. Membranes were blocked in 5% Carnation dry skim milk in
10 mM Tris–HCl (pH 8.0), 140 mM NaCl, for a least 1 h and probed
with UPT82 (see below) or preimmune serum diluted 1:3000 in
blocking buffer overnight. Following three washes of 5 min each in
0.1% Tween-20 TBS, the membrane was incubated for 1 h at room
temperature in biotinylated donkey anti-rabbit IgG (Jackson Re-
search Labs) diluted 1:5000 in blocking buffer. The membrane was
washed as above, incubated for 30 min in a 1:1000 dilution of
streptavidin–horseradish peroxidase conjugate (Amersham), and
washed as above. Bound antibody was detected by chemilumines-
cence (ECL Plus; Amersham). The same membranes were reprobed
with a 1:15,000 dilution of PATH52 antibody, generated against
epitopes between amino acids 255 and 753 of Dnmt1 (Carlson et
al., 1992).
Immunocytochemistry
Two new antibodies were generated to investigate the Dnmt1
and Dnmt1o expression in oocytes and preimplantation embryos.
UPT82 was generated by immunizing a rabbit with a fusion protein
that contained the full-length bacterial GST protein and the amino
terminal 118 amino acids of Dnmt1. These 118 amino acids are not
found in Dnmt1o. UPT82 was affinity purified on a column
containing a 6-histidine–118-amino-acid fusion protein. UPTC21
was generated by immunizing a chicken with a fusion protein of
6-histidine plus a segment of Dnmt1 from amino acid 636 to amino
acid 1108. These amino acids are present in both Dnmt1 and
Dnmt1o.
Denuded oocytes and preimplantation embryos were freed of the
zona pellucida by using acidified (pH 2.5) Tyrode’s medium (Hogan
et al., 1986), and fixed for 10–15 min at room temperature in 3.7%
formaldehyde in PBS. Alternatively, small ovarian follicles were
fixed intact. All solutions for immunofluorescence of Dnmt1 were
prepared in PBS and procedures were carried out at room tempera-
ture, unless specified otherwise. The fixed cells were blocked for at
least 1 h in blocking buffer (3% BSA, 0.1% Triton X-100) and then
incubated in either 1:100 preimmune serum, 1:100 UPT82, 1:100
UPTC21, or 1:500 PATH52 antibodies diluted in the same blocking
buffer overnight at 4°C in a humidified chamber. The cells were
washed three times for 5 min each in blocking buffer, then
incubated in 1:250 of goat-anti-rabbit Bodipy-TMRX secondary
antibody (Molecular Probes, Eugene, OR) or in 1:4000 of a rabbit-
anti-chicken secondary antibody for 1 h, and washed as before. To
FIG. 2. RT-PCR analyses of Dnmt1 mRNA splice variants in
tissues, ovaries, and oocytes. (A) Reverse transcription PCR (RT-
PCR) was performed on RNA samples isolated from different adult
tissues. The Dnmt1 transcript is identified as a 201-bp PCR
fragment using oligo 6 and oligo 5 in the PCR (Fig. 1A). The
Dnmt1o transcript is identified as a 235-bp PCR fragment using
oligo 7 and oligo 5 in the PCR (Fig. 1A). (B) RT-PCR analysis of
Dnmt1 and Dnmt1o transcripts from ovaries isolated from em-
bryos (E) at 17.5 to 18.5 days of development or ovaries isolated at
different days (D) following birth. (C) RT-PCR analysis of oocytes
isolated from different embryonic or postnatal stages.
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mount the cells for viewing, a drop of Vectashield mounting
medium (Vector Laboratories, Burlingame, CA) supplemented with
0.4 g/ml of the DNA-binding dye DAPI (Roche Diagnostics) was
placed on a glass microscope slide and the cells were transferred
into the drop with a pipette. A cover slip was gently placed on the
drop to spread the mounting medium and flatten the cells, and was
subsequently sealed with nail polish. Immunofluorescence was
visualized by using a Zeiss Axiophot, Zeiss LSM410 laser scanning
confocal microscope. All images were recorded under identical
laser settings. The specificity of the UPT82 antibody for the Dnmt1
protein was demonstrated by incubating the antibody with satu-
rating amounts of the Dnmt1-specific 118-aa polypeptide (with a
6-histidine tag at the N terminus) at 4°C overnight and adding it to
fixed embryos obtained from Dnmt11s/1o homozygous females.
Under these conditions, no staining was observed.
RESULTS
Expression of Dnmt1 mRNA Splice Variants in
Tissues and Isolated Oocytes
The relative positions of the three alternative first exons
(1o, 1s, and 1p) of the Dnmt1 gene are shown in Fig. 1A.
Exon 1s transcripts are translated into the 1620-aa Mr
190,000 Dnmt1 protein, whereas exon 1o transcripts are
translated into the 1502-aa Mr 175,000 Dnmt1o protein (Fig.
1B). The initiation codon for Dnmt1 is in exon 1s, whereas
the initiation codon for Dnmt1o is an internal methionine
codon of Dnmt1, located in the common exon 4 (Mertineit
et al., 1998; Yoder et al., 1996). Compared to Dnmt1o,
Dnmt1 contains an additional 118 amino acids at its amino
terminus (Fig. 1B). Portions of Dnmt1 used to generate
PATH52 (Carlson et al., 1992), UPT82, and UPTC21 poly-
clonal antisera are shown in Fig. 1B. To understand the
temporal and spatial patterns of Dnmt1 and Dnmt1o ex-
pression, we measured Dnmt1 and Dnmt1o transcript and
protein levels during development. Transcript expression
was determined by RT-PCR, and protein expression by
immunoblotting and immunocytochemistry.
Using a forward oligonucleotide primer (oligo 6) in exon
1s and a reverse primer (oligo 5) in exon 3, we measured
levels of Dnmt1 transcripts in adult tissues. Similarly,
Dnmt1o transcripts were measured by using a forward
oligonucleotide primer in exon 1o (oligo 7) and oligo 5. The
201-bp PCR product representing the Dnmt1 transcript was
present in all adult tissues examined. In contrast, the
235-bp Dnmt1o product was detected exclusively in post-
natal ovaries (Figs. 2A and 2B). To determine whether
transcript levels were associated with the growth and
maturation of oocytes, we measured Dnmt1 and Dnmt1o
transcripts in isolated oocytes at different stages of devel-
opment. As shown in Fig. 2C, Dnmt1 transcripts were
present at low levels in fetal oocytes and at higher levels in
postnatal oocytes at all stages. In contrast, Dnmt1o tran-
scripts were first detected in isolated oocytes as early as
postnatal day 5 and were subsequently seen at increasing
levels in all classes of growing oocytes. The amount of
Dnmt1o transcripts in MII oocytes was significantly less
than the level in GVBD-stage oocytes (data not shown). The
absence of Dnmt1o transcripts in isolated D1 oocytes (Fig.
2C), but its presence in D1 ovaries (Fig. 2B) is likely due to
the small number of manually collected oocytes used in the
RT-PCR assay and the preponderance of nongrowing oo-
cytes in the collection.
Immunoblotting and Immunostaining of Dnmt1
Protein Isoforms in Isolated Oocytes
The detection of Dnmt1 and Dnmt1o transcripts in growing
oocytes (D5 through D70 lanes in Fig. 2C) suggests that both
forms of the Dnmt1 protein might be present in these germ
cells. In MII oocytes, Dnmt1o was the only protein detected
on immunoblots using the PATH52 antibody; earlier stages of
oogenesis were not examined (Carlson et al., 1992). To deter-
mine more precisely the forms of Dnmt1 protein present in
oocytes at various stages of development, an antibody
(UPT82) was produced in a rabbit immunized with the
N-terminal 118 amino acids of Dnmt1. This antibody pro-
vides a means of directly detecting Dnmt1 protein in mouse
germ cells and cleavage-stage embryos.
Immunoblot analysis of oocytes at different stages of
growth showed no evidence of the Mr 190,000 form of
Dnmt1 after probing with the UPT82 antibody (Fig. 3A).
UPT82 detected only the Dnmt1 protein in lysates of
somatic cells or lysates of tissues with a mixture of somatic
and germ cells (D10 ovary, D10 Ut/Ovd, D49 Ov, and D70
Ts lanes in Fig. 3A). When the same membrane was
reprobed with the PATH52 antibody, only Dnmt1o (Mr
175,000) could be detected in lysates of postnatal oocytes
(Fig. 3B). No expression was seen in a lysate of 400 D1
oocytes. Dnmt1o protein was also detected in the D10 and
D49 ovaries (Fig. 3B). Thus, the presence of both Dnmt1
protein species in the ovaries appears to be due to the
full-length form in the proliferating somatic cells and the
truncated isoform in oocytes.
The immunoblotting data do not exclude a low level of
the Mr 190,000 form of Dnmt1 in one or more stages of
growing oocytes. We previously reported dynamic changes
in the amount and intracellular localization of one or more
forms of Dnmt1 protein in oocytes of postnatal ovaries
immunostained with the PATH52 antibody (Howell et al.,
2001; Mertineit et al., 1998). To test the possibility that the
Mr 190,000 Dnmt1 is one of the forms found in oocytes, but
is present at levels not detected on immunoblots (Fig. 3), we
immunostained small follicles and larger oocyte–granulosa
cell complexes with the UPT82 antibody. Confocal micros-
copy showed no evidence of Dnmt1 protein within MII
oocytes, whereas surrounding somatic granulosa cells were
intensely stained (Fig. 4A). In comparison, both MII oocytes
and granulosa cells were stained by the UPTC21 antibody
(Fig. 4B) and by the pATH52 antibody (Mertineit et al.,
1998). Even fully grown germinal vesicle-stage oocytes did
not stain with UPT82 (data not shown). These data are
consistent with the absence of Dnmt1 protein in mature
MII oocytes.
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Dnmt1 RNA and Protein Expression during
Preimplantation Development
Despite the lack of Dnmt1 protein expression in oocytes,
Dnmt1 protein might be expressed during preimplantation
development, either from maternal transcripts or from tran-
scripts produced de novo in the preimplantation embryo. To
address these possibilities, we first measured Dnmt1 and
Dnmt1o transcripts in preimplantation cleavage-stage em-
bryos. As shown in Fig. 5A, Dnmt1 transcripts were present at
all stages of preimplantation development, in steadily increas-
ing amounts from the one-cell embryo to the blastocyst. In
contrast, Dnmt1o transcripts were only found in the one-cell
embryo. Immunoblot analysis of early embryos using the
UPT82 antibody showed that the Mr 190,000 form of Dnmt1
was abundantly present in E7.5 embryos and in adult ovaries,
but was absent from all preimplantation cleavage stages (Fig.
5B). When the same membrane was reprobed with the
PATH52 antibody, only the Mr 175,000 Dnmt1o form was
observed in all preimplantation embryos (Fig. 5C). Thus,
Dnmt1 protein was not detected on immunoblots with an
antibody that detects epitopes present only in Dnmt1
(UPT82), nor with an antibody that detects epitopes common
to Dnmt1 and Dnmt1o (PATH52).
The UPT82 antibody was also used to stain cleavage-
stage preimplantation embryos. As shown in Fig. 4A, there
was no evidence of Dnmt1 protein in two, four-, and
eight-cell embryos, morulae, and blastocysts. In contrast,
when embryos of these stages were stained with UPTC21, a
staining pattern similar to PATH52 staining was observed
(Fig. 4B). These findings add further support to the notion
that Dnmt1o protein is the sole form of Dnmt1 in the
preimplantation embryo.
The possibility that Dnmt1 might provide maintenance
activity at preimplantation stages other than eight-cell
embryos was further tested by forcing the expression of
Dnmt1 in preimplantation stages and examining its intra-
cellular localization. There are two ways of forcing the
expression of Dnmt1 in preimplantation development. It
could be expressed in the oocyte’s cytoplasm, from which it
could traffic to different intracellular locations in preim-
plantation embryos, or Dnmt1 transcripts could be made
after fertilization, and then translated into Dnmt1 protein.
We took the first approach and forced the expression of
Dnmt1 protein in the oocyte. Using gene targeting tech-
niques in ES cells, the Dnmt1 locus was modified to express
Dnmt1 from the oocyte-specific promoter (Fig. 6). The 3
end of exon 1o was replaced by exon 1s sequences, so that
the modified exon 1o, designated exon 1s/1o, contains all
coding information found in exon 1s (Figs. 6A and 6B).
Oocyte-specific transcripts from this modified Dnmt1 al-
lele, designated Dnmt11s/1o, encode for Dnmt1 protein.
Homozygous mutant Dnmt11s/1o female mice produce MII
oocytes containing both the Mr 190,000 and the Mr 175,000
form of Dnmt1, as shown on immunoblots stained with
UPT82 and UPTC21 (Figs. 6E and 6F). Both forms of Dnmt1
protein are probably expressed because of the short 5 UTR
in the Dnmt11s/1o transcript and thus frequent translation
initiation from the methionine codon in exon 4. This codon
is normally the initiation codon for Dnmt1o protein pro-
duced from wildtype Dnmt1o transcripts. Preimplantation
embryos derived from these mutant oocytes also express
Dnmt1 protein (Fig. 4C). Interestingly, the time course of
nuclear localization of Dnmt1 protein in these embryos
parallels that of Dnmt1o protein in wildtype embryos, with
nuclear localization evident only at the eight-cell stage.
Cytoplasmic Dnmt1 protein evident in two-, four-, and
eight-cell embryos stained with UPT82 is different than the
pattern of cytoplasmic localization of Dnmt1o protein seen
in wildtype embryos (Carlson et al., 1992; Howell et al.,
2001). Cytoplasmic Dnmt1 protein from homozygous
Dnmt11s/1o oocytes is aggregated, whereas wild-type cyto-
plasmic Dnmt1o protein is more evenly distributed (Figs.
4B and 4C). The distribution of both forms is seen after
staining with the UPTC21 antibody (Fig. 4D). The differ-
ence in intracytoplasmic distribution of the two Dnmt1
forms is likely to be due to differences in the way the two
FIG. 3. Immunoblot of oocytes probed with Dnmt1 antibodies.
(A) Immunoblot probed with the UPT82 antibody identifies the Mr
190,000 Dnmt1 protein in lysates of pooled oocytes or lysates of
adult tissues. (B) Same blot as in (A), but probed with the PATH52
antibody that identifies both the Mr 175,000 Dnmt1o and the Mr
190,000 Dnmt1 proteins. Lysates from the following number of
oocytes were loaded: 400 D1 oocytes, 400 D5 oocytes, 200 D10
oocytes, 200 D15 oocytes, 50 GV oocytes, and 50 MII oocytes. The
following amount of protein from adult tissues were loaded: 10 g
of D10 ovary, 10 g of D10 uterus/oviduct, 15 g of D49 ovary, and
20 g of D70 testis. The presence of protein in all lanes was verified
by staining with Ponceau S. Shown is a one blot from two
independent experiments. GV, germinal vesicle stage; MII, meta-
phase II.
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proteins are stored in the oocyte’s cytoplasm and the way
they traffic after fertilization.
DISCUSSION
Dnmt1 and Dnmt1o in Oocytes and
Preimplantation Embryos
The process of genomic imprinting involves two crucial
steps: the establishment of DNA methylation patterns in
male and female gametes, and the subsequent maintenance
of these patterns following fertilization (Chaillet et al.,
1991). These steps occur in settings of dramatic changes in
the intracellular composition and localization of forms of
the Dnmt1 methytransferase (Carlson and Bestor, 1992;
Mertineit et al., 1998). In MII oocytes and in all preimplan-
tation cleavage-stage embryos, there are large amounts of
the Mr 175,000 Dnmt1o protein, approximately 50,000-fold
higher on a per-nucleus basis in the oocyte as compared to
the amount of Dnmt1 protein present in a cycling somatic
FIG. 4. Immunolocalisation and confocal microscopy of Dnmt1 isoforms in growing oocytes and ovarian follicles as well as
preimplantation embryos (two-cell to blastocyst stages). All the panels represent confocal Z-sections. (A) Immunostaining with UPT82 to
localize Dnmt1 in the wildtype embryos. (B) Immunostaining with UPTC21 to localize both Dnmt1 and Dnmt1o in the wildtype embryo.
(C) Immunostaining with UPT82 to localize Dnmt1 in embryos derived from homozygous Dnmt11s/1o mutant embryos. (D) Immunostain-
ing with UPTC21 to localize Dnmt1 and Dnmt1o in embryos derived from homozygous Dnmt11s/1o mutant females.
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cell (Carlson et al., 1992). Dnmt1o’s only known function
during the period spanning oocyte maturation and preim-
plantation development is to maintain methylation pat-
terns on imprinted genes during a single S phase of preim-
plantation development (Howell et al., 2001). Our
conclusion from the experiments presented here is that
methylation patterns at other S phases are not maintained
by the Mr 190,000 Dnmt1. Therefore, DNA cytosine meth-
yltransferases other than Dnmt1 are required for maintain-
ing imprints during preimplantation development.
The nucleocytoplasmic trafficking of oocyte-derived
Dnmt1o (in wildtype mice) and Dnmt1 (in Dnmt11s/1o mice)
proteins throughout preimplantation development is simi-
lar. Both proteins are primarily found in the cytoplasm of
cleavage-stage embryos, with exclusion from all nuclei
except those of eight-cell embryos. Despite their similar
nucleocytoplasmic trafficking, Dnmt1o and Dnmt1 (in
Dnmt11s/1o mice) proteins are found in different cytoplasmic
locations within MII oocytes, and within two- and four-cell
embryos. Whereas cytoplasmic Dnmt1o protein is uni-
formly concentrated near the plasma membrane in oocytes
and embryos, Dnmt1 protein is diffusely distributed in MII
oocytes, and found in cytoplasmic concentrates in both
two- and four-cell embryos (Fig. 4). The location of Dnmt1o
protein near the plasma membrane of mature oocytes,
two-cell embryos, and four-cell embryos may be due to
binding to annexin V, a calcium-sensitive phospholipid
binding protein (Howell et al., 2001; Ohsawa et al., 1996). If
Dnmt1 protein does not bind to annexin V because of the
additional 118 N-terminal amino acids, then it might
FIG. 5. Time course of Dnmt1 and Dnmt1o mRNA and protein expression during preimplantation development. (A) RT-PCR analyses of
Dnmt1 mRNA splice variants in preimplantation embryos, including morulae and blastocysts. Expression in metaphase II (MII) oocytes,
embryos at 7.5 days of development (D7.5 embryo), and adult ovary (D70 ovary) are also shown. (B) Immunoblot of lysates from different
preimplantation stages, probed with UPT82. A total of 30 mature oocytes and 30 embryos of each preimplantation stage were loaded. The
following amount of protein from embryonic tissues were loaded: 15 g of D7.5 postimplantation embryo and 15 g of D70 ovary. (C) Same
immunoblot as shown in (B), but probed with PATH52.
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FIG. 6. Dnmt11s/1o allele. (A) Targeted modification of the Dnmt1 locus by insertion of Dnmt1 1s exon sequences into exon 1o and
Cre-mediated excision of resistance cassette placed approximately 100 bp 3 of the modified exon 1o. H, HindIII; R, EcoRI; X, XbaI. Wildtype
Dnmt1 locus, targeting construct and recominant Dnmt11s/1o allele. (B) Sequences of exon 1o, exon 1s, and hybrid exon 1s/1o. The
underlined sequences in exon 1s replace the underlined sequences in exon 1o to give rise to the mutant exon 1s/1o. The amino acid codons
for exon 1s and exon 1s/1o are shown. The nucleotides represented in italics are the changes made in exon 1s to create SnaBI restriction
sites (TACGTA). These sites were used to replace a portion of exon 1o with exon 1s sequences. (C) Confirmation by Southern blot that
homologous recombination occurred in ES cells. DNA was cleaved with HindIII and the probe used is shown in (A). Lane 1, Wildtype ES
cells. Lane 2, Heterozygous recombinant ES cells. (D) PCR of tail DNA using primers flanking exon 1o and exon 1s/1o (shown by arrows
in A) distinguishes wildtype Dnmt1 and mutant Dnmt11s/1o alleles following Cre-mediated excision of the resistance cassette. Lane 1,
Homozygous mutant Dnmt11s/1o. Lane 2, Homozygous wildtype Dnmt1. Lane 3, Heterozygous Dnmt11s/1o/Dnmt1. (E) Immunoblot probed
with the UPT82 antibody shows the Mr 190,000 Dnmt1 somatic isoform in oocytes obtained from homozygous Dnmt11s/1o females. (F)
Immunoblot probed with the UPTC21 antibody reveals the Mr 175,000 Dnmt1o variant in addition to the Mr 190,000 Dnmt1 isoform in
oocytes obtained from homozygous Dnmt11s/1o females.
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become sequestered in organelles or in aggresomes. This
sequestration suggests that the majority of oocyte-derived
Dnmt1 protein is not available for subsequent trafficking to
nuclei of eight-cell embryos. Therefore, it is very likely that
a much greater fraction of the cytoplasmic store of Dnmt1o
protein moves to the nuclei in eight-cell embryos than does
the cytoplasmic store of Dnmt1 protein in Dnmt11s/1o
oocytes.
Although Dnmt1 and Dnmt1o proteins have very similar
in vitro DNA methyltransferase activities (Carlson et al.,
1992), their DNA methyltransferase activities may differ in
the nuclei of preimplantation embryos. One way this might
occur is through the interaction of Dnmt1 and Dnmt1o
with different proteins. The only known protein that inter-
acts with the 118 amino acids at the amino terminus of
Dnmt1 is DMAP1 (Rountree et al., 2000). The function of
DMAP1 is not known, but it is feasible that specific
interactions with the amino terminus of Dnmt1 by DMAP1
or other unknown proteins would regulate its DNA meth-
yltransferase activity.
We can make important inferences about the origins of
the Dnmt1o protein and the Dnmt1 protein (from the
Dnmt11s/1o allele) seen in oocytes and preimplantation
cleavage stages. Because Dnmt1o transcripts are not de-
tected after division of the one-cell embryo, all preimplan-
tation Dnmt1o protein is probably derived from oocyte
stores of Dnmt1o protein. This interpretation is consistent
with the maternal effect inheritance pattern of the
Dnmt11o mutation (Howell et al., 2001). Interestingly, no
Dnmt1 protein was detected in wildtype MII oocytes de-
spite the presence of Dnmt1 transcripts, yet Dnmt1 protein
can be made in the oocyte from the Dnmt11s/1o allele. These
observations suggest that the protein translation machinery
of fully grown oocytes distinguishes Dnmt1 transcripts
from Dnmt1o and Dnmt11s/1o transcripts. Differences in the
5 UTRs of these transcripts (Fig. 5) may determine the
observed differences in oocyte-specific translation.
Relevance to Cloning of Mammals
Our findings may have implications for the success of the
cloning of mammals. The cloning of mammals by trans-
plantation of somatic nuclei into enucleated zygotes or
ooplasts has been plagued by low recoveries of viable clonal
offspring and unpredictable phenotypic variation among the
survivors (Humpherys et al., 2001; Tamashiro et al., 2000;
Young and Fairburn, 2000). While this has been explained
by reference to failures to reprogram unidentified aspects of
chromatin structure, specific differences between nuclei of
somatic cells and preimplantation embryos have been dif-
ficult to identify. We report here that preimplantation
embryos of certain cleavage stages are completely free of
Dnmt1 protein, which is present in nuclei of cycling
somatic cells, and likely to be present in the donor nuclei
used in cloning experiments. Transplantation of somatic
nuclei into ooplasts therefore introduces a form of Dnmt1
protein that is foreign to preimplantation embryos and
which might be responsible in part for the abnormal
genomic methylation (Kang et al., 2001; Ohgane et al.,
2001) and developmental abnormalities commonly seen in
offspring derived by transplantation of somatic nuclei.
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